Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.88 is 25% above its 5-year average of 4.72, around the middle of its 5-year range (3.05–7.86).
As of the fiscal period ended Tuesday, June 30, 2026. 9.80% below its 12-month average of 6.52.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.88.
CURRENT RATIO
5.88
CURRENT RATIO AVG TTM
6.52
CURRENT RATIO AVG 3Y
5.24
CURRENT RATIO AVG 5Y
4.72
CURRENT RATIO AVG 10Y
4.68
CURRENT RATIO AVG 15Y
6.67
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.80%
CURRENT VS 3Y AVG
+12.11%
CURRENT VS 5Y AVG
+24.64%
CURRENT VS 10Y AVG
+25.55%
CURRENT VS 15Y AVG
-11.86%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.12
median of 442 covered companies
CURRENT VS SECTOR MEDIAN
+88.43%
vs the sector median at left
Arcturus Therapeutics Holdings Inc.
Market Cap
$416.68M
Current Ratio
5.88
TTM Avg
6.52
3Y Avg
5.24
5Y Avg
4.72
Market Cap
$410.54M
Current Ratio
8.13
TTM Avg
16.34
3Y Avg
21.67
5Y Avg
17.16
Market Cap
$408.21M
Current Ratio
9.89
TTM Avg
6.34
3Y Avg
6.34
5Y Avg
6.34
Market Cap
$406.47M
Current Ratio
10.71
TTM Avg
7.83
3Y Avg
8.94
5Y Avg
8.94
Market Cap
$447.43M
Current Ratio
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$450.64M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
Market Cap
$453.70M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $416.68M | 5.88 | 6.52 | 5.24 | 4.72 |
| Carlsmed, Inc. (CARL)vs › | $415.93M | 8.84 | 7.23 | 5.35 | 5.35 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.54M | 8.13 | 16.34 | 21.67 | 17.16 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $408.21M | 9.89 | 6.34 | 6.34 | 6.34 |
| Shoulder Innovations, Inc. (SI)vs › | $406.47M | 10.71 | 7.83 | 8.94 | 8.94 |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | 3.19 | 3.65 | 4.66 | 6.11 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | 7.35 | 8.39 | 5.06 | 6.73 |
| Assembly Biosciences, Inc. (ASMB)vs › | $450.64M | 13.99 | 3.82 | 4.25 | 5.96 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | 6.72 | 10.04 | 13.74 | 16.43 |
| Canopy Growth Corporation (CGC)vs › | $373.40M | 3.04 | 3.23 | 2.34 | 4.58 |
Current Ratio
5.88
Quick Ratio
5.88
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.88 |
| 2026-03-31 | 6.31 |
| 2025-12-31 | 6.64 |
| 2025-09-30 | 7.86 |
| 2025-06-30 | 5.90 |
| 2025-03-31 | 5.64 |
| 2024-12-31 | 4.67 |
| 2024-09-30 | 4.76 |
| 2024-06-30 | 3.78 |
| 2024-03-31 | 3.26 |
| 2023-12-31 | 4.72 |
| 2023-09-30 | 4.49 |
| 2023-06-30 | 4.26 |
| 2023-03-31 | 4.71 |
| 2022-12-31 | 3.18 |
| 2022-09-30 | 3.25 |
| 2022-06-30 | 3.14 |
| 2022-03-31 | 3.05 |
| 2021-12-31 | 3.81 |
| 2021-09-30 | 3.56 |
| 2021-06-30 | 6.19 |
| 2021-03-31 | 8.81 |
| 2020-12-31 | 9.45 |
| 2020-09-30 | 11.21 |
| 2020-06-30 | 6.16 |
| 2020-03-31 | 2.94 |
| 2019-12-31 | 3.48 |
| 2019-09-30 | 3.66 |
| 2019-06-30 | 3.86 |
| 2019-03-31 | 2.51 |
| 2018-12-31 | 3.33 |
| 2018-09-30 | 2.53 |
| 2018-06-30 | 2.28 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 4.61 |
| 2017-09-30 | 17.60 |
| 2017-06-30 | 25.42 |
| 2017-03-31 | 21.08 |
| 2016-12-31 | 11.82 |
| 2016-09-30 | 15.97 |
| 2016-06-30 | 18.70 |
| 2016-03-31 | 25.95 |
| 2015-12-31 | 22.26 |
| 2015-09-30 | 14.57 |
| 2015-06-30 | 14.46 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 9.32 |
| 2014-09-30 | 6.25 |
| 2014-06-30 | 8.41 |
| 2014-03-31 | 13.57 |
| 2013-12-31 | 30.70 |
| 2013-09-30 | 15.40 |
| 2013-06-30 | 63.21 |
| 2013-03-31 | 0.00 |
| 2012-12-31 | 0.23 |
| 2012-09-30 | 0.00 |
| 2012-06-30 | 0.00 |
